Literature DB >> 2554308

Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA.

R M del Angel1, A G Papavassiliou, C Fernández-Tomás, S J Silverstein, V R Racaniello.   

Abstract

The 5' noncoding region of poliovirus RNA contains sequences necessary for translation and replication. These functions are probably carried out by recognition of poliovirus RNA by cellular and/or viral proteins. Using a mobility-shift electrophoresis assay and 1,10-phenanthroline/Cu+ footprinting, we demonstrate specific binding of cytoplasmic factors with a sequence from nucleotides 510-629 within the 5' untranslated region (UTR). Complex formation was also observed with a second sequence (nucleotides 97-182) within the 5' UTR. These two regions of the 5' UTR appear to be recognized by distinct cell factors as determined by competition analysis and the effects of ionic strength on complex formation. However, both complexes contain eukaryotic initiation factor 2 alpha, as revealed by their reaction with specific antibody.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554308      PMCID: PMC298268          DOI: 10.1073/pnas.86.21.8299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence.

Authors:  M A Skinner; V R Racaniello; G Dunn; J Cooper; P D Minor; J W Almond
Journal:  J Mol Biol       Date:  1989-05-20       Impact factor: 5.469

2.  Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication.

Authors:  S Kuge; A Nomoto
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  An RNA sequence of hundreds of nucleotides at the 5' end of poliovirus RNA is involved in allowing viral protein synthesis.

Authors:  D Trono; R Andino; D Baltimore
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

4.  Comparative sequence analysis of the 5' noncoding region of the enteroviruses and rhinoviruses.

Authors:  V M Rivera; J D Welsh; J V Maizel
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

5.  An internal 5'-noncoding region required for translation of poliovirus RNA in vitro.

Authors:  K Bienkowska-Szewczyk; E Ehrenfeld
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

6.  Footprinting DNA-protein complexes in situ following gel retardation assays using 1,10-phenanthroline-copper ion: Escherichia coli RNA polymerase-lac promoter complexes.

Authors:  M D Kuwabara; D S Sigman
Journal:  Biochemistry       Date:  1987-11-17       Impact factor: 3.162

7.  Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.

Authors:  N La Monica; C Meriam; V R Racaniello
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

8.  Phosphorylation of eukaryotic initiation factor 2 during physiological stresses which affect protein synthesis.

Authors:  K A Scorsone; R Panniers; A G Rowlands; E C Henshaw
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

9.  Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5' noncoding region.

Authors:  J Pelletier; G Kaplan; V R Racaniello; N Sonenberg
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

10.  Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA.

Authors:  J Pelletier; N Sonenberg
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

View more
  66 in total

1.  Cap-independent translation by the 5' untranslated region of Theiler's murine encephalomyelitis virus.

Authors:  P K Bandyopadhyay; C Wang; H L Lipton
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Specific interactions of HeLa cell proteins with proposed translation domains of the poliovirus 5' noncoding region.

Authors:  J R Gebhard; E Ehrenfeld
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Intracellular modifications induced by poliovirus reduce the requirement for structural motifs in the 5' noncoding region of the genome involved in internal initiation of protein synthesis.

Authors:  N Percy; G J Belsham; J K Brangwyn; M Sullivan; D M Stone; J W Almond
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

4.  Internal entry of ribosomes on a tricistronic mRNA encoded by infectious bronchitis virus.

Authors:  D X Liu; S C Inglis
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

Review 5.  Mechanism and regulation of eukaryotic protein synthesis.

Authors:  W C Merrick
Journal:  Microbiol Rev       Date:  1992-06

6.  Conservation of RNA-protein interactions among picornaviruses.

Authors:  S L Dildine; B L Semler
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

7.  A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA.

Authors:  K Shiroki; T Ishii; T Aoki; M Kobashi; S Ohka; A Nomoto
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Cell proteins bind to a linear polypyrimidine-rich sequence within the 5'-untranslated region of rhinovirus 14 RNA.

Authors:  I A Rojas-Eisenring; M Cajero-Juarez; R M del Angel
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Effects of antisense oligodeoxynucleotide hybridization on in vitro translation of potato virus Y RNA.

Authors:  C Levis; M Tronchet; M Meyer; J Albouy; S Astier-Manifacier
Journal:  Virus Genes       Date:  1992-01       Impact factor: 2.332

10.  An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses.

Authors:  N M Chapman; Z Tu; S Tracy; C J Gauntt
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.